About the Szent-Györgyi Prize
The Szent-Györgyi Prize for Progress in Cancer Research is named in memory of Dr. Albert Szent-Györgyi, NFCR’s co-founder and 1937 Nobel Laureate for his study of vitamin C and cell respiration. The prize is a symbol of NFCR’s enduring commitment to uphold Dr. Szent-Györgyi’s vision of curing cancer through innovation and collaboration.
The annual Prize honors scientists whose seminal discovery or pioneering body of work has contributed to cancer prevention, diagnosis, or treatment and has had a lasting impact on understanding cancer, holding the promise of improving or saving lives of cancer patients.
The Szent-Györgyi Prize serves to stimulate continued investment in the pioneering research that will produce scientific breakthroughs and promote public awareness of the importance of basic cancer research and the need to accelerate the translation of these research discoveries into new cancer treatments. In addition to winning the coveted award itself, prize recipients are given a $30,000 honorarium and attend a gala in their honor.
Our 2025 Winner, Tony Hunter, M.D., was honored on October 24, 2025, at the National Press Club in Washington, D.C.
JUST ANNOUNCED:
Dr. Michele Carbone of the University of Hawaii Cancer Center is our 2026 Szent-Györgyi Prize for Progress in Cancer Research Winner
Learn More About His Landmark Discovery and Lasting Impact >>>
Current Winner
Dr. Michele Carbone is recognized for his landmark discovery that mesothelioma is driven by an inherited gene.
About the Ceremony
Our next ceremony will take place on October 9, 2026 in Washington, DC.
Past Winners
View all previous awardees of the Szent-Gyorgyi Prize for Progress in Cancer Research.
